InvestorsHub Logo
Followers 52
Posts 5558
Boards Moderated 0
Alias Born 07/03/2020

Re: hnbadger1 post# 400206

Friday, 01/27/2023 10:33:52 AM

Friday, January 27, 2023 10:33:52 AM

Post# of 470701
What Kun Jin knows will be more important. If he were the FDA biostatistician in charge of reviewing the submissions for Aduhelm and Leqembi, as has been stated here, he is the perfect person to make the case that blarcamesine is statistically superior to either of them. No one would have better credentials for that role.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News